Trospium Chloride Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 20 mg, 60 mg
Reference Brands: Sanctura (USA), Spasmex (EU)
Category:
Women's Health
Trospium Chloride is available in Tablets
and strengths such as 20 mg, 60 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Trospium Chloride is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Trospium Chloride can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Trospium chloride is a muscarinic receptor antagonist used primarily to manage overactive bladder (OAB), helping reduce urinary urgency, frequency, and incontinence. It works by blocking muscarinic receptors in the bladder smooth muscle, which decreases involuntary contractions and improves bladder control.
Unlike some other muscarinic antagonists, trospium chloride has minimal central nervous system effects, making it a safer option for patients who may be sensitive to cognitive side effects. Common side effects include dry mouth, stomach upset, and constipation, which may affect adherence if not managed properly. Trospium chloride is administered orally, usually on an empty stomach to maximize absorption, and is generally well-tolerated under medical supervision. Its targeted action on the bladder muscles makes it a reliable choice for improving quality of life in patients with overactive bladder.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing